Anzeige
Mehr »
Sonntag, 01.03.2026 - Börsentäglich über 12.000 News
Erste Psilocybin-Behandlungen laufen - warum steht Optimi noch bei Pennystock-Level?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2N7LY | ISIN: US8257041090 | Ticker-Symbol: 2K3
Frankfurt
27.02.26 | 15:25
13,400 Euro
+2,29 % +0,300
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SI-BONE INC Chart 1 Jahr
5-Tage-Chart
SI-BONE INC 5-Tage-Chart
RealtimeGeldBriefZeit
13,00013,10019:05
13,10013,40027.02.

Aktuelle News zur SI-BONE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiSI-BONE, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
DiSI-BONE, Inc. - 10-K, Annual Report2
DiTruist erhöht Kursziel für SI-BONE nach starkem Quartal4
DiTruist raises SI-BONE stock price target on strong quarter2
DiSI-BONE outlines 14%-16% revenue growth for 2026 with new product launches and Smith & Nephew partnership2
DiSI-BONE Q4 2025 slides: profitability milestone as revenue tops $200M1
SI-BONE Aktie jetzt für 0€ handeln
MoSmith+Nephew signs distribution deal with SI-BONE for pelvic implants2
MoSmith & Nephew Plc: Smith+Nephew signs distribution agreement with SI-BONE738Trauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term value for surgeons and patients Smith+Nephew (LSE:SN, NYSE:SNN), the global...
► Artikel lesen
MoSI-BONE Q4 Earnings Assessment1
MoSI-BONE, Inc. - 8-K, Current Report2
MoSI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 Guidance581Achieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025Generates free cash flow in the Fourth Quarter 2025 SANTA CLARA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- SI-BONE...
► Artikel lesen
03.02.SI-BONE To Report Q4 And FY2025 Results This Month; What Does Preliminary Results Indicate?-
02.02.SI-BONE, Inc.: SI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 20261
27.01.A Glimpse Into The Expert Outlook On SI-BONE Through 5 Analysts1
27.01.TD Cowen initiates coverage on SI-BONE stock with Buy rating2
12.01.SI-BONE, Inc.: SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025222SANTA CLARA, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised...
► Artikel lesen
12.01.SI-BONE, Inc. - 8-K, Current Report-
07.01.Why Did SI-Bone (SIBN) Surge Spike After Hours?3
16.12.25SI-BONE stock price target raised to $27 by Needham, named top pick for 20262
11.11.25Why SI-Bone Stock Was Crushing It Today7
Weiter >>
31 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1